Horacio Zamudio-Meza

Cross-talk between Rac1 and Cdc42 GTPases regulates formation of filopodia required for dengue virus type-2 entry into HMEC-1 cells.

Horacio Zamudio-Meza, Aída Castillo-Alvarez, C. González-Bonilla, 2009, The Journal of general virology.

A Shift Towards an Immature Myeloid Profile in Peripheral Blood of Critically Ill COVID-19 Patients

H. Mayani, N. Wacher, J. Torres, 2020, Archives of Medical Research.

Gene signature based on degradome-related genes can predict distal metastasis in cervical cancer patients

C. Pérez-Plasencia, Horacio Zamudio-Meza, C. López-Camarillo, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

The role of melatonin in the neurodevelopmental etiology of schizophrenia: A study in human olfactory neuronal precursors

C. Trueta, G. Benítez-King, Horacio Zamudio-Meza, 2017, Journal of pineal research.

Actin cytoskeleton participation in the onset of IL-1beta induction of an invasive mesenchymal-like phenotype in epithelial MCF-7 cells.

Horacio Zamudio-Meza, I. Meza, E. García-Zepeda, 2010, Archives of medical research.

CBD Reverts the Mesenchymal Invasive Phenotype of Breast Cancer Cells Induced by the Inflammatory Cytokine IL-1β

Horacio Zamudio-Meza, I. Meza, M. C. Domínguez-Robles, 2020, International journal of molecular sciences.

IL-1β Inflammatory Cytokine-Induced TP63 Isoform ∆NP63α Signaling Cascade Contributes to Cisplatin Resistance in Human Breast Cancer Cells

Horacio Zamudio-Meza, I. Meza, J. Ayala-Sumuano, 2019, International journal of molecular sciences.

Rho signaling in Entamoeba histolytica modulates actomyosin-dependent activities stimulated during invasive behavior.

Horacio Zamudio-Meza, I. Meza, N. Villegas-Sepúlveda, 2006, Cell motility and the cytoskeleton.

Insulin‑like growth factor axis: A potential nanotherapy target for resistant cervical cancer tumors (Review)

Horacio Zamudio-Meza, J. Narayanan, Jorge Fernández-Retana, 2023, Oncology letters.

MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.

C. Pérez-Plasencia, Horacio Zamudio-Meza, L. Herrera, 2018, Oncology reports.